CombiMatrix to Present at Upcoming Investment Conferences
September 22 2015 - 6:00AM
CombiMatrix Corporation (NASDAQ:CBMX), a molecular diagnostics
company specializing in DNA-based testing services for prenatal and
postnatal developmental disorders and pre-implantation genetic
screening services, announces that President and Chief Executive
Officer Mark McDonough will present a company overview at the
upcoming investment conferences:
- Ladenburg Thalmann 2015 Healthcare Conference
on Tuesday, September 29, 2015, at 4:00 p.m. Eastern time (1:00
p.m. Pacific time). The conference is being held at the Sofitel New
York hotel in New York City.
- 2015 Aegis Capital Growth Conference on
Friday, October 9, 2015, at 10:45 a.m. Pacific time (1:45 p.m.
Eastern time). The conference is being held at the Encore at
Wynn Las Vegas hotel in Las Vegas.
A live webcast of the presentation at the Ladenburg Thalmann
Conference will be available on the company's website at
http://investor.combimatrix.com/events.cfm and will be archived for
30 days.
About CombiMatrix Corporation
CombiMatrix Corporation provides valuable molecular diagnostic
solutions and comprehensive clinical support to foster the highest
quality in patient care. CombiMatrix specializes in prenatal
diagnostics, miscarriage analysis for recurrent pregnancy loss,
pediatric genetics and pre-implantation genetic screening, offering
DNA-based testing for the detection of genetic abnormalities beyond
what can be identified through traditional methodologies.
CombiMatrix performs genetic testing utilizing a variety of
advanced cytogenomic techniques, including chromosomal microarray,
standardized and customized fluorescence in situ hybridization
(FISH) and high-resolution karyotyping. CombiMatrix is dedicated to
providing high-level clinical support for healthcare professionals
in order to help them incorporate the results of complex genetic
testing into patient-centered medical decision making. Additional
information about CombiMatrix is available at www.combimatrix.com
or by calling (800) 710-0624.
CONTACT: Company Contact:
Mark McDonough
President & CEO, CombiMatrix Corporation
(949) 753-0624
Investor Contact:
LHA
Jody Cain
(310) 691-7100
jcain@lhai.com
Russo Partners LLC
David Schull or Lena Evans
(212) 845-4271
david.schull@russopartnersllc.com
lena.evans@russopartnersllc.com
Combimatrix Corp. (MM) (NASDAQ:CBMX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Combimatrix Corp. (MM) (NASDAQ:CBMX)
Historical Stock Chart
From Apr 2023 to Apr 2024